Search

Author/Creator Rousselet, M.‐C.

1. Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C. Issue 2 (2nd June 2014)

Authors:
Boursier, J.; Brochard, C.; Bertrais, S.; Michalak, S.; Gallois, Y.; Fouchard‐Hubert, I.; Oberti, F.; Rousselet, M.‐C.; Calès, P.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 40:Issue 2(2014)
Page Start:
178
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH. Issue 10 (25th March 2018)

Authors:
Boursier, J.; Anty, R.; Vonghia, L.; Moal, V.; Vanwolleghem, T.; Canivet, C. M.; Michalak, S.; Bonnafous, S.; Michielsen, P.; Oberti, F.; Iannelli, A.; Van Gaal, L.; Patouraux, S.; Blanchet, O.; Verrijken, A.; Gual, P.; Rousselet, M.‐C.; Driessen, A.; Hunault, G.; Bertrais, S.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 10(2018)
Page Start:
1387
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search